title: [Anti-tumour necrosis factor treatment in HIV-positive patients with psoriatic arthritis].
authors.forename: Tatiana
authors.initials: T
authors.lastname: Cobo Ibáñez
authors.forename: Francisco
authors.initials: F
authors.lastname: Zamora
authors.forename: Pedro
authors.initials: P
authors.lastname: Herranz
authors.forename: Martina
authors.initials: M
authors.lastname: Steiner
mesh_terms: D000328:Adult; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000209:etiology*; D000068800:Etanercept; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept